OpenAI has collaborated with Retro Biosciences to develop GPT-4b micro, a specialized version of GPT-4o for protein engineering. This AI model successfully designed novel variants of Yamanaka factors, which demonstrated over a 50-fold increase in stem cell reprogramming markers in vitro. The research, validated across multiple cell types and donors, also indicated enhanced DNA damage repair capabilities, suggesting greater rejuvenation potential. OpenAI is sharing insights into GPT-4b micro's development to foster broader life sciences innovation. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON OpenAI developed a specialized AI model (GPT-4b micro) and published research detailing its application in life sciences, which falls under research rather than a frontier model release.
